About Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
9
Pfizer
8
Bio Products Laboratory
2
Janssen Research & Development, LLC
2
Maria Sklodowska-Curie National Research Institute of Oncology
2
Blueprint Medicines Corporation
1
Cornerstone Pharmaceuticals
1
Genmab
1
Jazz Pharmaceuticals
1
Kartos Therapeutics, Inc.
1
MaaT Pharma
1
Clinical Trials at Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii
During the past decade, Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 13 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 5 clinical trials were completed. i.e. 41.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
2009-02-01
2012-01-01
Completed
126
Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
2008-12-15
2014-10-27
Completed
129
Study to Evaluate 13 Valent Pneumococcal Conjugate Vaccine (13vPnC) Vaccine Followed by 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients
2010-01-18
2013-05-16
Completed
251
A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial)
2010-04-30
2020-04-27
Completed
329
A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)
2011-07-26
2018-01-31
Terminated
1,418
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
2011-04-18
2017-11-17
Completed
240
A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia
2012-08-02
2017-01-04
Completed
326
A Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemophilia A.
2001-10-01
Completed
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Pfizer" with 8 trials
sponsored, "Bio Products Laboratory" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Maria Sklodowska-Curie National Research Institute of Oncology"
with 2 trials sponsored. Other sponsors include 7 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii"
#1 collaborator was "Chugai Pharmaceutical" with 4 trials as a collaborator, "KCRI" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator and "Janssen Biotech, Inc., including Johnson & Johnson" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii
According to Clinical.Site data, the most researched conditions in "Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii" are
"Hemophilia A" (3 trials), "Hemophilia A or B" (2 trials), "Multiple Myeloma" (2 trials), "Paroxysmal Nocturnal Hemoglobinuria" (2 trials) and "ACUTE LYMPHOBLASTIC LEUKEMIA" (1 trials). Many other conditions were trialed in "Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii" in a lesser frequency.
Clinical Trials Intervention Types at Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii
Most popular intervention types in "Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii" are "Drug" (29 trials), "Biological" (7 trials), "Procedure" (2 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (3 trials), "Placebo" (3 trials), "Rituximab" (3 trials), "Crovalimab" (2 trials) and "Dexamethasone" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii
The vast majority of trials in "Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii" are
33 trials for "All" genders and 2 trials for "Male" genders.
Clinical Trials Status at Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii
Currently, there are 17 active trials in "Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii".
2 are not yet recruiting,
10 are recruiting,
4 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 16 completed trials in Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii, 3 "Phase 1"
clinical trials were conducted, 15 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 0 trials that are defined as “Not Applicable".